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Abstract
A Conditional-Generative Adversarial Network has been used for a supervised image-to-image transla-
tion task which outputs a synthetic PET scan based on real patient CT data. The network is trained using
only data of patients with healthy bone marrow metabolism. This allows for a patient specific synthetic
healthy baseline scan to be produced. This can be used by a clinician for comparison to real PET data in the
absence of a baseline scan or to aid in the diagnosis of conditions such as Multiple Myeloma which manifest
as changes in bone marrow metabolism.
Keywords: Medical Imaging, Conditional-Generative Adversarial Networks, Deep Learning, PET-CT,
Bone Marrow.
1 Introduction
1.1 Multiple Myeloma
Multiple myeloma (MM) is a malignant haematologic disorder characterized by bone marrow (BM) infiltra-
tion with neoplastic plasma cells. Approximately 10% of all haematologic cancers are related to MM, with
an incidence of approximately 4/100,000 per year [Bredella et al., 2005]. Bone lesions are present in approx-
imately 80% of symptomatic patients. The extent of bone lesions will impact later choices of therapy and
it is therefore vital to diagnose myelomatous lesions accurately and as non-invasively as possible. In order
to standardize treatment approaches it is essential that the disease be clearly characterised at the time of di-
agnosis, this is achieved through the Durie-Salmon staging system for MM which was introduced in 1975
[Durie and Salmon, 1975]. Advances in diagnostic imaging techniques led to the introduction of the Durie-
Salmon PLUS staging system in 2003 [Fechtner et al., 2010]. The Durie-Salmon PLUS system highlights the
benefits of 18F-FDG PETCT in accurate staging of MM [Durie, 2006] which can show regions of the bone and
BM that demonstrate signs of elevated metabolism.
1.2 PETCT
Positron Emission Tomography Computed Tomography (PETCT) imaging utilizes 18F-fluorodeoxyglucose
(18F-FDG), which is an analogue of glucose that has positron-emitting radionuclide 18F attached to the
molecule. Metabolically active cells take up the 18F-FDG which remains trapped within the cell and is then
imaged using PET [Bredella et al., 2005]. The Standard Uptake Value (SUV) is used as a diagnostic tool to
semi-quantitatively differentiate between benign and malignant anatomic regions, such as the lesions caused by
MM [Hallett et al., 2001]. The semi-quantitative nature of SUV measurements allows for a more objective as-
sessment of PET images. At present, there is an ever growing body of evidence to suggest PETCT’s increasing
importance in the future of MM diagnosis [Touzeau and Moreau, 2013].
1.3 Conditional-Generative Adversarial Networks (C-GANs)
The framework first proposed by [Goodfellow et al., 2014] simultaneously trains a generative model G that
captures the data distribution, and a discriminative model D that determines whether a sample came from
the training data or was artificially generated by G. At each training step the goal for G is to maximize the
probability of D making a mistake. In the original GAN framework there is no control over the output sample,
it is initialized using a random noise distribution. By adding in a conditional component, in this case the CT
image, the output, in this case the PET, must relate to the conditional component. The task is a supervised
image-to-image translation where a CT image is translated to a PET image [Huang et al., 2018].
2 Methods
Shown here is an example of Coronal pro-
jections of the original CT, the BM mask ap-
plied to CT, and the BM mask when applied
to the PET component.
The work presented trains a C-GAN which uses the CT compo-
nent of the scan to infer a corresponding synthetic PET compo-
nent. Images have been filtered and masks applied to retain only
regions relating to the bone marrow. The network is trained us-
ing datasets of patients considered to have normal/healthy bone
marrow metabolism and so produce corresponding healthy ar-
tificial PET component which can then be compared to the real
patient PET scan. Differences may indicate signs of malignancy.
Qualitative comparison is presented in the form of visual com-
parison of the outputs from the trained network when given a
dataset of both a healthy BM patient and a patient with MM.
2.1 Training Data
After receiving ethical approval by the institution, PET-CT scans
of 10 patients were compiled. The data was anonymised prior
to analysis to ensure compliance with data protection procedures. All scans performed on the same Siemens
Biograph 16 PETCT scanner. All scans used in the study were oncology related, with patient referrals indicating
a history of cancer. The scan reports were reviewed to ensure the PET component of the patient scan was
considered to show normal levels of BM metabolism and had not received recent therapy or intervention which
could impact normal BM metabolism.
2.2 Preprocessing
All data processing and C-GAN development was carried out using a combination of Matlab software (for im-
age processing steps) and Python via Spyder interface (for C-GAN and Tensorflow steps). PETCT data were
loaded and images calibrated using the dicom metadata to convert to medical image standards of Hounsfield
Units (HU) and Standard Uptake Value (SUV) and resampled from (1 x 1 x 3) mm3 to (1 x 1 x 1) mm3. The
software first segments cortical bone from the CT component of the PETCT data. Segmentation was based upon
thresholding of pixel values followed by a series of region filling and region growing steps, to ensure both the
cortical bone and red marrow bone are part of the segmentation [Puri et al., 2012] [Martínez-Martínez et al., 2016].
This results in a bone marrow binary mask that can be applied to the already mechanically co-registered PET
data through a pixel-wise matrix multiplication operation [Sambuceti et al., 2012]. The various stages in the
creation of a bone marrow binary mask are shown in figure above.
2.3 Training the Network
The network applied here is a modified version of the Tensorflow (GPU version 2.0) implementation of the
PIX2PIX network described by Isola et al, for more details of the hyperparameters set, additional image pro-
cessing and overall architecture see [Isola et al., 2017]. Training data consisted of approximately 6,000 PETCT
axial slices from the 10 patient dataset. This was split into 15 batches which ran for 160 epochs. Training took
approximately 13 hours to complete using a 6 GB Nvidia Geforce 1060 graphics card.
3 Results
Once the network was trained is could then be used to create synthetic PET images based on the CT component
alone. An entire series of axial CT slices were fed into the network to produce the corresponding synthetic
PET volume. This was done for both a healthy bone marrow patient not used in training and a patient with a
diagnosis of MM. In order to further assess differences between between the real PET and the synthetic PET
the 3D volumes were first filtered using a mean filter of size 21 x 21 x 21 to reduce impact of noise and then
a pixel-wise subtraction between the real and synthetic data was performed to highlight regions where the real
data had a greater pixel value, and hence metabolism, than predicted. The results are presented in the figures
below as Maximum Intensity Projection images in the coronal plane.
Figure 1: The main differences in BM metabolism relate to a lack of diffuse activity in the sacrum as well in
the left acetabulum of the synthetic PET and are not suggestive of malignancy.
Figure 2: The main differences in BM metabolism relate to numerous focal regions of activity consistent with
a diagnosis of MM.
4 Conclusions
The synthetic PET is based on a network which has been trained only on data of patients with healthy BM
metabolism. This is a bias of the network which means when given CT data of a patient with unhealthy BM
metabolism it will predict the healthy corresponding synthetic PET scan. The results show differences are
present in both the healthy and myeloma test data. This is to be expected as, despite the large number of im-
ages used, only 10 patients were used in training, and this will not be enough to capture normal variances in
metabolism seen between healthy patients. The differences between the MM patient do highlight several re-
gions of focal uptake which is consistent with a diagnosis of MM. Further refinement of the proposed technique
will involve more training data, quantitative analysis of the network’s performance and fine tuning of network
hyper-parameters.
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